Floatz logo

[212pb]pb-mp0712

Other DLL3 Expressing epNEC

Molecular Partners AGradiopharmaceuticalPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Other DLL3 Expressing epNEC cohort.

Asset / SponsorPhaseRating
[203Pb]Pb-MP0712
Molecular Partners AG
Phase 1/2CCC

Same molecule, other indications

[212pb]pb-mp0712 is also rated in:

large cell neuroendocrine carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
pulmonary large cell neuroendocrine carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
Gastroenteropancreatic NEC (GEP NEC)Dormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →